Market research
PDEX Pro-Dex Inc
NASDAQ USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 188M
- P/E ratio
- 14.53
- Analyst target
- 74
- Dividend yield
- Not available
- Beta
- 0.04
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- Not available
- Market cap
- 188M
- P/E ratio
- 14.53
- Analyst target
- 74
- Dividend yield
- Not available
- Beta
- 0.04
About
About Pro-Dex Inc
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Research context
Pro-Dex Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the PDEX discussion.
5 years, 6 months ago
Pro-Dex, Inc is currently in a long term downtrend where the price is trading 3.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
Pro-Dex, Inc's total revenue rose by 3.8% to $8M since the same quarter in the previous year.
Its net income has dropped by 73.0% to $337K since the same quarter in the previous year.
Finally, its free cash flow fell by 445.8% to $-5M since the same quarter in the previous year.
Based on the above factors, Pro-Dex, Inc gets an overall score of 2/5.